Загрузка...
Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases
PURPOSE: To (1) examine the occurrence and concentrations of aPS/PT and aPL in inflammatory bowel disease (IBD) patients at the beginning of and during anti-TNF-alpha therapy with infliximab; (2) investigate the link of the aPS/PT and aPL presence with antibodies to infliximab (ATI) formation; and (...
Сохранить в:
| Опубликовано в: : | Auto Immun Highlights |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4389083/ https://ncbi.nlm.nih.gov/pubmed/26000139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13317-012-0045-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|